Subscribe To
VKTX / 1 Under-the-Radar Stock That Could Triple By 2030
![1 Under-the-Radar Stock That Could Triple By 2030](https://cdn.snapi.dev/images/v1/k/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7533112fdoctor-and-patient-talkingjpgopresizew400h400-2140400.jpg)
VKTX News
![1 Under-the-Radar Stock That Could Triple By 2030 1 Under-the-Radar Stock That Could Triple By 2030](https://cdn.snapi.dev/images/v1/k/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7533112fdoctor-and-patient-talkingjpgopresizew400h400-2140400.jpg)
By The Motley Fool
November 4, 2023
1 Under-the-Radar Stock That Could Triple By 2030
Viking Therapeutics is looking to profit from the expanding market for obesity drugs. The company's two leading candidates are currently in phase 2 cl more_horizontal
![Why Is Viking Therapeutics (VKTX) Stock Moving Today? Why Is Viking Therapeutics (VKTX) Stock Moving Today?](https://cdn.snapi.dev/images/v1/g/8/medicine-2108974.jpg)
By InvestorPlace
October 18, 2023
Why Is Viking Therapeutics (VKTX) Stock Moving Today?
Viking Therapeutics (NASDAQ: VKTX ) stock is on the move Wednesday as the clinical-stage biopharmaceutical company reveals data from a clinical trial. more_horizontal
![Viking Therapeutics joins weight loss drug bandwagon as trial data impresses Viking Therapeutics joins weight loss drug bandwagon as trial data impresses](https://cdn.snapi.dev/images/v1/9/a/shutterstock-604196579-652fbc1cd2498-2108322.jpg)
By Proactive Investors
October 18, 2023
Viking Therapeutics joins weight loss drug bandwagon as trial data impresses
Viking Therapeutics (NASDAQ:VKTX) shares shot up 12% in overnight US trading as the drug developer revealed more impressive trial data from a treatmen more_horizontal
![Viking Therapeutics' stock rallies following early drug study data Viking Therapeutics' stock rallies following early drug study data](https://cdn.snapi.dev/images/v1/w/z/biotech39-2107694.jpg)
By Market Watch
October 17, 2023
Viking Therapeutics' stock rallies following early drug study data
Viking Therapeutics Inc. VKTX, -0.37% shares rose in the extended session Tuesday after the biotech drug developer said data from an early stage clini more_horizontal
![Why Viking Therapeutics Is Plunging Today Why Viking Therapeutics Is Plunging Today](https://cdn.snapi.dev/images/v1/n/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7377092fdownward-trendjpgopresizew400h400-1950240.jpg)
By The Motley Fool
June 27, 2023
Why Viking Therapeutics Is Plunging Today
After positive mid-stage data, Eli Lilly seems to have a chance at achieving best-in-class status in the valuable weight loss market. Viking's shares more_horizontal
![Why Viking Therapeutics Stock Is Crashing Today Why Viking Therapeutics Stock Is Crashing Today](https://cdn.snapi.dev/images/v1/g/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7375552fcrashing-arrowjpgopresizew400h400-1948822.jpg)
By The Motley Fool
June 26, 2023
Why Viking Therapeutics Stock Is Crashing Today
A top competitor announced plans to move forward with a late-stage weight loss candidate today. Viking's weight-loss candidate is several years behind more_horizontal
![Could Viking Therapeutics Stock Help You Become a Millionaire? Could Viking Therapeutics Stock Help You Become a Millionaire?](https://cdn.snapi.dev/images/v1/u/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7361392fa-team-of-scientists-reviewing-results-in-a-labjpgopresizew400h400-1938535.jpg)
By The Motley Fool
June 17, 2023
Could Viking Therapeutics Stock Help You Become a Millionaire?
Viking Therapeutics has a few drugs that have the potential to generate billions in revenue. The problem is that they are in early-stage trials, so th more_horizontal
![This Red-Hot Growth Stock Has Soared 885% in Just 12 Months This Red-Hot Growth Stock Has Soared 885% in Just 12 Months](https://cdn.snapi.dev/images/v1/t/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7350292fsurprised-and-excited-person-looking-at-a-laptopjpgopresizew400h400-1926621.jpg)
By The Motley Fool
June 8, 2023
This Red-Hot Growth Stock Has Soared 885% in Just 12 Months
Viking Therapeutics is a biotech with multiple potential blockbuster drugs in its portfolio. Encouraging trial results have made investors bullish abo more_horizontal